Creatine kinase IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
09-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Abbott Australasia Pty Ltd Diagnostic Division
Class:
Class 3
Manufactured by:
Abbott Laboratories Diagnostics Division 100 Abbott Park Road, Abbott Park, IL, 60064 United States Of America
Therapeutic area:
CT831 - Creatine kinase IVDs
Therapeutic indications:
For the determination of creatine kinase in human clinical specimens.
Authorization status:
A
Authorization date:
2014-01-23
